These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29509636)

  • 1. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
    J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis.
    Philpott H; Nandurkar S; Royce SG; Thien F; Gibson PR
    Aliment Pharmacol Ther; 2016 May; 43(9):985-93. PubMed ID: 26939578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia.
    Gómez-Torrijos E; García-Rodríguez R; Castro-Jiménez A; Rodríguez-Sanchez J; Méndez Díaz Y; Molina-Infante J
    Aliment Pharmacol Ther; 2016 Feb; 43(4):534-40. PubMed ID: 26662868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
    Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
    Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.
    Laserna-Mendieta EJ; Casabona S; Guagnozzi D; Savarino E; Perelló A; Guardiola-Arévalo A; Barrio J; Pérez-Martínez I; Lund Krarup A; Alcedo J; de la Riva S; Rey-Iborra E; Santander C; Arias Á; Lucendo AJ;
    Aliment Pharmacol Ther; 2020 Sep; 52(5):798-807. PubMed ID: 32677040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT6 Variants Associate With Relapse of Eosinophilic Esophagitis in Patients Receiving Long-term Proton Pump Inhibitor Therapy.
    Mougey EB; Nguyen V; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Borrell B; Román E; González-Lois C; Chao M; Al-Atrash H; Franciosi JP
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2046-2053.e2. PubMed ID: 32798708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis: Predictive Factors and Long-Term Step-Down Efficacy.
    Gutiérrez-Junquera C; Fernández-Fernández S; Domínguez-Ortega G; Vila Miravet V; García-Puig R; La Orden-Izquierdo E; Peña Quintana L; Barrio Torres J; Medina Benítez E; Leis R; García-Romero R; Fernández de Valderrama A; Vecino López R; Donado Palencia P;
    J Pediatr Gastroenterol Nutr; 2023 Feb; 76(2):191-198. PubMed ID: 36416845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
    Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
    Eur J Pediatr; 2024 Aug; 183(8):3567-3578. PubMed ID: 38819501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative long-term treatment of children with eosinophilic esophagitis.
    Levine J; Lai J; Edelman M; Schuval SJ
    Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor.
    Vazquez-Elizondo G; Ngamruengphong S; Khrisna M; Devault KR; Talley NJ; Achem SR
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1312-9. PubMed ID: 24117619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study.
    Dellon ES; Speck O; Woodward K; Gebhart JH; Madanick RD; Levinson S; Fritchie KJ; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2013 Dec; 108(12):1854-60. PubMed ID: 24145677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis.
    Molina-Infante J; Rodriguez-Sanchez J; Martinek J; van Rhijn BD; Krajciova J; Rivas MD; Barrio J; Moawad FJ; Martinez-Alcalá C; Bredenoord AJ; Zamorano J; Dellon ES
    Am J Gastroenterol; 2015 Nov; 110(11):1567-75. PubMed ID: 26416193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
    Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
    Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.
    Dohil R; Newbury RO; Aceves S
    Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
    Molina-Infante J; Katzka DA; Gisbert JP
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1157-64. PubMed ID: 23656497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
    Frandsen LT; Westmark S; Melgaard D; Krarup AL
    United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis.
    Oliva S; Rossetti D; Papoff P; Tiberti A; Mallardo S; Volpe D; Ruggiero C; Russo G; Vezzoli D; Isoldi S; Cucchiara S
    Dig Dis Sci; 2019 Jun; 64(6):1571-1578. PubMed ID: 30659470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.